Transcriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicans

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 4, 2008, Pages 1481-1492

  Manoharlal, Raman ^a   Gaur, Naseem Akhtar ^a,c   Panwar, Sneh Lata ^a   Morschhäuser, Joachim ^b   Prasad, Rajendra ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BETA GALACTOSIDASE; CARRIER PROTEIN; FLUCONAZOLE; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PROTEIN CDR1; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; FUNGUS ISOLATION; GENE ACTIVITY; GENE CONSTRUCT; GENE FUSION; GENE LOCUS; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC CODE; HALF LIFE TIME; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; RNA STABILITY; RNA TRANSLATION; TRANSCRIPTION INITIATION;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; RNA STABILITY; RNA, FUNGAL; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS);

EID: 42049094413     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01106-07     Document Type: Article

References (48)

1. Akins, R. A. 2005. An update on antifungal targets and mechanisms of resistance in Candida albicans. Med. Mycol. 43:285-318.
2. Chen, C. G., Y. L. Yang, H. I. Shih, C. L. Su, and H. J. Lo. 2004. CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1. Antimicrob. Agents Chemother. 48:4505-4512.
3. Coste, A. T., M. Karababa, F. Ischer, J. Bille, and D. Sanglard. 2004. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot. Cell 3:1639-1652.
4. Coste, A., V. Turner, F. Ischer, J. Morschhäuser, A. Forche, A. Selmecki, J. Berman, J. Bille, and D. Sanglard. 2006. A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics 172:2139-2156.
5. de Micheli, M., J. Bille, C. Schueller, and D. Sanglard. 2002. A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol. Microbiol. 43:1197-1214.
6. Franz, R., M. Ruhnke, and J. Morschhäuser. 1999. Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 42:453-458.
7. Franz, R., S. L. Kelly, D. C. Lamb, D. E. Kelly, M. Ruhnke, and J. Morschhäuser. 1998. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42:3065-3072.
8. Garcia-Martinez, J., A. Aranda, and J. E. Perez-Ortin. 2004. Genomic run-on evaluates transcription rates for all yeast genes and identifies gene regulatory mechanisms. Mol. Cell 15:303-313.
9. Gardner, R. G., G. M. Swarbrick, N. W. Bays, S. R. Cronin, S. Wilhovsky, L. Seelig, C. Kim, and R. Y. Hampton. 2000. Endoplasmic reticulum degradation requires lumen to cytosol signaling: transmembrane control of Hrd1p by Hrd3p. J. Cell Biol. 151:69-82.
10. Gaur, N. A., N. Puri, N. Karnani, G. Mukhopadhyay, S. K. Goswami, and R. Prasad. 2004. Identification of a negative regulatory element which regulates basal transcription of a multidrug resistance gene CDR1 of Candida albicans. FEMS Yeast Res. 4:389-399.
11. Gaur, N. A., R. Manoharlal, P. Saini, T. Prasad, G. Mukhopadhyay, M. Hoefer, J. Morschhäuser, and R. Prasad. 2005. Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element. Biochem. Biophys. Res. Commun. 332:206-214.
12. Haque, A., V. Rai, B. S. Bahal, S. Shukla, A. A. Lattif, G. Mukhopadhyay, and R. Prasad. 2007. Allelic variants of ABC drug transporter Cdr1p in clinical isolates of Candida albicans. Biochem. Biophys. Res. Commun. 352: 491-497.
13. Hiller, D., D. Sanglard, and J. Morschhäuser. 2006. Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans. Antimicrob. Agents Chemother. 50:1365-1371.
14. Hiller, D., S. Stahl, and J. Morschhäuser. 2006. Multiple cis-acting sequences mediate upregulation of the MDR1 efflux pump in a fluconazole-resistant clinical Candida albicans isolate. Antimicrob. Agents Chemother. 50:2300-2308.
15. Holmes, A. R., S. Tsao, S. W. Ong, E. Lamping, K. Niimi, B. C. Monk, M. Niimi, A. Kaneko, B. R. Holland, J. Schmid, and R. D. Cannon. 2006. Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2. Mol. Microbiol. 62:170-186.
16. Imanishi, Y., K. Yokoyama, and K. Nishimura. 2004. Inductions of germ tube and hyphal formations are controlled by mRNA synthesis inhibitor in Candida albicans. Nippon Ishinkin Gakkai Zasshi 45:113-119.
17. Karnani, N., N. A. Gaur, S. Jha, N. Puri, S. Krishnamurthy, S. K. Goswami, G. Mukhopadhyay, and R. Prasad. 2004. SRE1 and SRE2 are two specific steroid-responsive modules of Candida drug resistance gene 1 (CDR1) promoter. Yeast 21:219-239.
18. Kebaara, B. W., L. E. Nielsen, K. W. Nickerson, and A. L. Atkin. 2006. Determination of mRNA half-lives in Candida albicans using thiolutin as a transcription inhibitor. Genome 49:894-899.
19. Kimchi-Sarfaty, C., J. M. Oh, I. W. Kim, Z. E. Sauna, A. M. Calcagno, S. V. Ambudkar, and M. M. Gottesman. 2007. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315:525-528.
20. Krishnamurthy, S., V. Gupta, R. Prasad, S. L. Panwar, and R. Prasad. 1998. Expression of CDR1, a multidrug resistance gene of Candida albicans: in vitro transcriptional activation by heat shock, drugs and human steroid hormones. FEMS Microbiol. Lett. 160:191-197.
21. Li, D., V. Gurkovska, M. Sheridan, R. Calderone, and N. Chauhan. 2004. Studies on the regulation of the two-component histidine kinase gene CHK1 in Candida albicans using the heterologous lacZ reporter gene. Microbiology 150:3305-3313.
22. Lopez-Camarillo, C., J. P. Luna-Arias, L. A. Marchat, and E. Orozco. 2003. EhPgp5 mRNA stability is a regulatory event in the Entamoeba histolytica multidrug resistance phenotype. J. Biol. Chem. 278:11273-11280.
23. Lopez-Ribot, J. L., R. K. McAtee, L. N. Lee, W. R. Kirkpatrick, T. C. White, D. Sanglard, and T. F. Patterson. 1998. Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob. Agents Chemother. 42:2932-2937.
24. Lyons, C. N., and T. C. White. 2000. Transcriptional analyses of antifungal drug resistance in Candida albicans. Antimicrob Agents Chemother. 44: 2296-2303.
25. Muller, C., F. Goubin, E. Ferrandis, I. Cornil-Scharwtz, J. D. Bailly, C. Bordier, J. Benard, B. I. Sikic, and G. Laurent. 1995. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells. Mol. Pharmacol. 47:51-56.
26. Murad, A. M., C. d'Enfert, C. Gaillardin, H. Tournu, F. Tekaia, D. Talibi, D. Marechal, V. Marchais, J. Cottin, and A. J. Brown. 2001. Transcript profiling in Candida albicans reveals new cellular functions for the transcriptional repressors CaTup1, CaMig1 and CaNrg1. Mol. Microbiol. 42:981-993.
27. Nieto, A., D. Guillermo Perez, E. Orozco, F. Paz, and C. Gomez. 2005. Entamoeba histolytica EhPgp5 transcriptional activation depends on putative emetine response elements. Exp. Parasitol. 110:233-237.
28. Ohki, R., and K. Tateno. 2004. Increased stability of bmr3 mRNA results in a multidrug-resistant phenotype in Bacillus subtilis. J. Bacteriol. 186:7450-7455.
29. Prasad, R., P. D. Worgifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
30. Prasad, T., P. Saini, N. A. Gaur, R. A. Vishwakarma, L. A. Khan, Q. M. Haq, and R. Prasad. 2005. Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in multidrug resistance and morphogenesis of Candida albicans. Antimicrob Agents Chemother. 49:3442-3452.
31. Prokipcak, R. D., A. Raouf, and C. Lee. 1999. The AU-rich 3′ untranslated region of human MDR1 mRNA is an inefficient mRNA destabilizer. Biochem. Biophys. Res. Commun. 261:627-634.
32. Puri, N., S. Krishnamurthy, S. Habib, S. E. Hasnain, S. K. Goswami, and R. Prasad. 1999. CDR1, a multidrug resistance gene from Candida albicans, contains multiple regulatory domains in its promoter and the distal AP-1 element mediates its induction by miconazole. FEMS Microbiol. Lett. 180: 213-219.
33. Reuss, O., A. Vik, R. Kolter, and J. Morschhäuser. 2004. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341:119-127.
34. Higgle, P. J., and C. A. Kumamoto. 2006. Transcriptional regulation of MDR1, encoding a drug efflux determinant, in fluconazole-resistant Candida albicans strains through an Mcm1p binding site. Eukaryot. Cell 5:1957-1968.
35. Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59:423-450.
36. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
37. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1997. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143: 405-416.
38. Sanglard, D., K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
39. Scotto, K. W., and R. A. Johnson. 2001. Transcription of the multidrug resistance gene MDR1: a therapeutic target. Mol. Interv. 1:117-125.
40. Setiadi, E. R., T. Doedt, F. Cottier, C. Noffz, and J. F. Ernst. 2006. Transcriptional response of Candida albicans to hypoxia: linkage of oxygen sensing and Efg1p-regulatory networks. J. Mol. Biol. 361:399-411.
41. Shukla, S., P. Saini, Smriti, S. Jha, S. V. Ambudkar, and R. Prasad. 2003. Functional characterization of Candida albicans ABC transporter Cdr1p. Eukaryot. Cell 2:1361-1375.
42. Uhl, M. A., and A. D. Johnson. 2001. Development of Streptococcus thermophilus lacZ as a reporter gene for Candida albicans. Microbiology 147: 1189-1195.
43. Wang, D., A. D. Johnson, A. C. Papp, D. L. Kroetz, and W. Sadee. 2005. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet. Genomics 15:693-704.
44. White, T. C. 1997. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increased azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41:1482-1487.
45. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.
46. Wirsching, S., S. Michel, G. Kohler, and J. Morschhäuser. 2000. Activation of the multidrug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a irans-regulatory factor. J. Bacteriol. 182:400-404.
47. Yague, E., A. L. Armesilla, G. Harrison, J. Elliott, A. Sardini, C. F. Higgins, and S. Raguz. 2003. P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation. J. Biol. Chem. 278:10344-10352.
48. Yang, Y. L., Y. H. Lin, M. Y. Tsao, C. G. Chen, H. I. Shih, J. C. Fan, J. S. Wang, and H. L. Lo. 2006. Serum repressing efflux pump CDR1 in Candida albicans. BMC Mol. Biol. 7:22.